Upper tract urothelial carcinoma (UTUC) is a relatively rare yet aggressive malignancy.
While radical nephroureterectomy (RNU) remains the cornerstone treatment, UTUC has …

Introduction: Limitations in tumor staging and the heterogeneous natural evolution of pT1
urothelial bladder carcinoma (UBC) make the choice of treatment challenging. We evaluated …

Purpose: We sought to assess the prognostic value of variant histology in patients with
upper tract urothelial carcinoma treated with radical nephroureterectomy. Materials and …

Objectives To investigate the effect of variant histology (VH) on survival after radical
nephroureterectomy in patients with upper urinary tract urothelial carcinoma (UTUC) and the …

Objective. Diagnostic reliability of prenephroureterectomy ureteroscopy (PNU) for the
detection of upper tract carcinoma in situ (CIS) remains unproven in particular and …

PURPOSE: We investigated the clinicopathological outcomes of patients treated with
cystectomy for pure urothelial carcinoma vs urothelial carcinoma, and squamous and/or …

Purpose: pT1 urothelial carcinoma of the bladder is a potentially aggressive cancer
diathesis with heterogeneous clinical behaviors. We tested whether the combination of …

OBJECTIVES: To evaluate if preoperative symptom classification could refine prediction of
outcomes for patients with clinically localized upper-tract urothelial carcinoma (UTUC) …

BACKGROUND: Dissimilarities in management and outcomes exist between upper tract
urothelial carcinoma (UTUC) and urothelial carcinoma of the bladder (UCB). OBJECTIVE …

Objective. Due to their variable oncological course, clinical stage T1 (cT1) urothelial
carcinomas of the bladder (UCBs) are the subject of controversial discussion with regard to …